Medicared For All Logo

Mary Klix MD in Anchorage, Alaska

Home Alaska Anchorage

Mary Klix MD has Medical Oncology as her primary medical specialty. Their primary office is: 2925 Debarr Rd in Anchorage, Alaska.

They're a part of the: Alaska Oncology And Hematology Llc medical group which has around 9 members. You can call their office at 907-279-3155 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Missouri, Columbia School Of Medicine and graduated in 1997 (around 27 years of experience). They are listed as doing telehealth appointments.


Mary M Klix MD Office Phone and Directions

Mary Klix MD
Alaska Oncology And Hematology Llc
2925 Debarr Rd
Anchorage, Alaska 99508
907-279-3155


Patient Ratings
Please rate your experience with Mary Klix MD below to help others make a more informed decision. Thanks!
Current Rating: Loading...

Phone: 907-279-3155


Enter a starting address:


Healthcare Info for Mary Klix MD

Additional Medical Specialties Include:
HEMATOLOGY

Medical School: University Of Missouri, Columbia School Of Medicine
Graduation Year: 1997
The Primary Medical Specialty for Mary Klix MD is listed as: Medical Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 27
PAC (PECOS ID)#: 8224019435
NPI #: 1669447595
NPI Created On: 02/22/2006
NPI Last Updated Listed as: 05/23/2018
Primary Taxonomy Code: 207RH0003X
License Number:
112773
Listed Gender: Female

Procedures, Services, Charges


Services and Procedures include:

  1. Ct scan chest with contrast
  2. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
  3. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
  4. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
  5. Infusion of chemotherapy into a vein up to 1 hour
  6. Infusion of chemotherapy into a vein
  7. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
  8. Irrigation of implanted venous access drug delivery device
  9. New patient office or other outpatient visit, typically 45 minutes
  10. New patient office or other outpatient visit, typically 60 minutes
  11. Established patient office or other outpatient visit, typically 10 minutes
  12. Established patient office or other outpatient visit, typically 15 minutes
  13. Established patient office or other outpatient, visit typically 25 minutes
  14. Established patient office or other outpatient, visit typically 40 minutes
  15. Initial hospital inpatient care, typically 70 minutes per day
  16. Subsequent hospital inpatient care, typically 15 minutes per day
  17. Subsequent hospital inpatient care, typically 25 minutes per day
  18. Subsequent hospital inpatient care, typically 35 minutes per day
  19. Injection, dexamethasone sodium phosphate, 1 mg
  20. Injection, palonosetron hcl, 25 mcg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.


Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540067

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: DARZALEX

Open Associated Drug #1: 57894-502-05

Drug or Biological: Biological

Product Category #2: Oncology

Name Of Drug #2:: IMBRUVICA

Associated Drug #2: 57962-140-09


Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788540069

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30


Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011955

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 781011957

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: IMBRUVICA

Open Associated Drug #1: 57962-420-28


Payments Total: $12

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802327411

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01


Payments Total: $29

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802826351

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: ONCOLOGY

Name of Drug #1: BLENREP

Open Associated Drug #1: 0173-0896-01


Payments Total: $5

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149695

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149747

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: PADCEV

Open Associated Drug #1: 51144-030-01


Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149759

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: TUKYSA

Open Associated Drug #1: 51144-001-60


Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 832149807

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: ADCETRIS

Open Associated Drug #1: 51144-050-01


Medical Oncology Professionals in Anchorage

3900 Ambassador Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

2925 Debarr Rd
Anchorage, AK
Alaska Oncology And Hematology Llc

3900 Ambassador Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

3851 Piper St
Anchorage, AK
Katmai Oncology Group Llc

3900 Ambassador Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

4315 Diplomacy Dr
Anchorage, AK
Alaska Native Tribal Health Consortium

Providers in Alaska Oncology And Hematology Llc

1.Mary Klix Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Medical Oncology

2.Steven Liu Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Medical Oncology

3.Max Rabinowitz Md

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Hematology/oncology

4.Jeremy Rosiecki

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Physician Assistant

5.Mary Stewart

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Hematology/oncology

6.Pamela Tittle

2925 Debarr Rd
Anchorage Ak 99508-2974
Alaska Oncology And Hematology Llc
Physician Assistant

View all 9 members of Alaska Oncology And Hematology Llc medical group